Babu Yarlagadda S

CIK 00014526351 companyBIRMINGHAM, AL

SEC Profile

Transactions

Companies

Filings

CIK

0001452635

Recent Transactions

50 trades

Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-11-14−50,000→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-11-14$13.88/sh−31,515→ 298,541 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-11-14−50,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-11-14$1.42/sh+50,000→ 330,056 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-11-14$1.42/sh+50,000→ 280,056 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-03-07$17.16/sh−20,000→ 230,056 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-12-14+164,000→ 164,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+35,000→ 250,056 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-07$4.73/sh+62,000→ 245,156 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-12-07−62,000→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-07$12.20/sh−30,100→ 215,056 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-02-19$11.53/sh−22,431→ 183,156 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Stock Option (Right to Buy)
2021-02-19−50,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-02-19$4.15/sh+50,000→ 205,587 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-15+280,000→ 280,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-03+17,000→ 17,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-21+18,000→ 18,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-14+31,500→ 31,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-12-17+225,000→ 225,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-11-18$1.45/sh+25,000→ 155,587 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-31$8.68/sh−1,685→ 130,587 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-31−12,188→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-31$1.20/sh+19,686→ 127,786 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-31$1.20/sh+12,188→ 132,272 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2019-01-31−19,686→ 0 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-31$8.68/sh−7,702→ 120,084 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-01$8.07/sh−771→ 108,100 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-12-20+235,000→ 235,000 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-03-06$5.18/sh−15,223→ 105,395 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-03-06−9,378→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-03-06$3.26/sh+9,378→ 114,773 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2018-03-06−20,622→ 0 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-03-06$5.18/sh−5,902→ 108,871 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-03-06$3.26/sh+20,622→ 120,618 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-01-20$5.59/sh−3,872→ 99,996 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-01-01$4.91/sh−838→ 103,868 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2017-12-20+100,000→ 100,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2017-08-31+27,000→ 27,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2017-02-27+175,000→ 175,000 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2017-01-20$5.95/sh−5,083→ 104,706 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2017-01-01$6.33/sh−1,639→ 109,789 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2016-08-25$4.06/sh−30,000→ 111,428 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2016-05-23+129,427→ 129,427 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2016-03-01$2.13/sh−906→ 141,428 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2016-01-20$7.55/sh−4,724→ 142,334 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2016-01-01$10.32/sh−1,639→ 147,058 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2015-12-29+62,573→ 62,573 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2015-05-13+17,000→ 17,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2015-03-19$10.16/sh−12,105→ 148,697 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2015-03-05$10.59/sh−37,400→ 160,802 total

Companies

BIOCRYST PHARMACEUTICALS INC
VP Drug Discovery
$BCRX

Recent Filings

Address

2190 PARKWAY LAKE DR

BIRMINGHAM, AL, 35244

View on SEC.gov